http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Shinsuke Mikami ),( Takafumi Sugihiro ),( Satoshi Mouri ),( Yusuke Ueda ),( Hitoshi Susawa ),( Kengo Kobayashi ),( Haruki Tanaka ),( Kouichi Tanaka ),( Yukihito Higashi ),( Yasuki Kihara ) 대한내과학회 2014 대한내과학회 추계학술발표논문집 Vol.2014 No.1
Background: Foot ulcers are costly complication among diabetes patients. These patients have an increased risk of amputation and increased mortality rate. Early recognition of the high-risk foot and sufficient care will save legs and improve patients` quality of life. Figures of incidence of foot ulcers varies and there are only limited information in relation the change of incidence over time. The aim of this study was to estimate 5-year risk for diabetic foot ulcer (DFU), lower extremity amputation (LEA) and all cause of death. Methods: Retrospective cohort study including all subjects with diabetes enrolled in our diabetic outpatient clinic from beginning 2008 until middle 2014. Data were collected from clinical records. Results: 528 subjects with mean age of 61.3 (±13.8), 57.4% were male. The mean of HbA1c in diabetic patients at baseline were 8.1% +/- 1.9%. Cumulative incidence was 1.3% for DFU, 0.18% for LEA and 4.7% for all-cause of death. The prevalence of cardiovascular and cerebrovascular conditions, pneumonia were 2.3%, 1.9%, 2.3%, respectively. Cause of deaths was cancer (64%), pneumonia (20%), cardiovascular death (4%). Conclusions: Several factors may explain the incidence in diabetes-related LEAs. Diabetes prevention strategies and controlling risk factors are important in people with type 1 and 2 diabetes.
Yoshihide Kanno,Tetsuya Ohira,Yoshihiro Harada,Shinsuke Koshita,Takahisa Ogawa,Hiroaki Kusunose,Yoshiki Koike,Taku Yamagata,Toshitaka Sakai,Kaori Masu,Keisuke Yonamine,Kazuaki Miyamoto,Megumi Tanaka,T 대한소화기내시경학회 2021 Clinical Endoscopy Vol.54 No.3
Background/Aims: The aim of this study was to evaluate the safety of sedation with propofol as an alternative to benzodiazepinedrugs in outpatient endoscopy. Methods: In this prospective study, examinees who underwent outpatient endoscopy under propofol sedation and submitted a nextdayquestionnaire with providing informed consent were evaluated. Periprocedural acute responses, late adverse events within 24hours, and examinee satisfaction were evaluated. Results: Among the 4,122 patients who received propofol in the 17,978 outpatient-based endoscopic examinations performedbetween November 2016 and March 2018, 2,305 eligible examinees (esophagogastroduodenoscopy for 1,340, endoscopicultrasonography for 945, and total colonoscopy for 20) were enrolled, and their responses to a questionnaire were analyzed. Themean propofol dose was 69.6±24.4 mg (range, 20–200 mg). Diazepam, midazolam, and/or pentazocine in combination withpropofol was administered to 146 examinees. Mild oxygen desaturation was observed in 59 examinees (2.6%); and mild bradycardia,in 2 (0.09%). Other severe reactions or late events did not occur. After eliminating 181 invalid responses, 97.7% (2,065/2,124) of thepatients desired propofol sedation in future examinations. Conclusions: Propofol sedation was found to be safe-without severe adverse events or accidents-for outpatient endoscopy on thebasis of the patients’ next-day self-evaluation. Given the high satisfaction level, propofol sedation might be an ideal tool for painlessendoscopic screening.